Unigen Launches Unigen Beauty; Director of Cosmeceutical Bioactives Joins Team

Tacoma, Washington-January 9, 2022: Unigen has announced the launch of Unigen Beauty, the company’s cosmeceutical ingredient division comprised of clinically proven, patented, and naturally derived bioactives. This unique portfolio offers a diverse line of novel cosmetic ingredients for skin health and beauty derived from Unigen’s Phytologix® Platform, a combination of nature, science, traditional medicinal botanicals, and dermatological screening technology.

Dr. Qi Jia, President and CEO of Unigen, states that “Unigen has extensive experience and industry reputation in the commercialization of natural bioactives such as Nivitol (UP302) in premier global brands of even skin tone products. It is an exciting time to launch Unigen Beauty with a portfolio of clinically proven and patented natural ingredients addressing consumer needs in skin aging, skin protection against pollution and UV exposure, skin sensitivity and hyper pigmentation.”

Additionally, Unigen is excited to welcome Anne W. Young, PhD, as the newly appointed Director of Cosmeceutical Bioactives. Dr. Young will lead business development and global sales of Unigen Beauty, discovery and development of Unigen’s cosmeceutical ingredient portfolio and pipeline. She brings extensive knowledge of global Personal and Skin Care bioactives, finished product brands and trends, customer needs and industry connections.

“Dr. Young’s well-rounded experience and expertise in the Cosmetic Industry, makes her an invaluable asset to lead Unigen’s new Unigen Beauty division. Her wealth of knowledge in research and development, technical writing, problem solving, and B2B sales is a perfect match to lead our new division,” says Rodney E. Storms, JD, Unigen’s Vice President, Sales & Marketing.

Dr. Young graduated with her M.S. and PhD in Chemistry from NYU Graduate School of Arts and Science. She started her career in the Personal Care Industry in 2010 as a Senior Scientist at Johnson & Johnson Consumer & Personal Products where she led several new product development initiatives. Her depth of experience includes raw material portfolio management at L’Oréal USA and new business development of everything from global accounts to Indie brands for BASF, Vantage and Expanscience Laboratoires. Additionally, Dr. Young has served on the Biotech INCI committee and filed several patents pertaining to the use of bioactive peptides in the Cosmetic Industry.

ABOUT UNIGEN INC.

Unigen discovers, develops, and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The Company discovers its ingredients through its high throughput screening PhytoLogix® approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits.

Mechanism of action, safety and efficacy are documented with extensive preclinical in vitro and in vivo testing and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution, and marketing of end-products in each of Unigen’s target markets.